In this issue

Jonathan Tobin: Defending the Right to a Jewish State

Heather Hale: Compliment your kids without giving them big heads

Megan Shauri: 10 ways you are ruining your own happiness

Carolyn Bigda: 8 Best Dividend Stocks for 2015

Kiplinger's Personal Finance editors: 7 Things You Didn't Know About Paying Off Student Loans

Samantha Olson: The Crucial Mistake 55% Of Parents Are Making At Their Baby's Bedtime

Densie Well, Ph.D., R.D. Open your eyes to yellow vegetables

The Kosher Gourmet by Megan Gordon With its colorful cache of purples and oranges and reds, COLLARD GREEN SLAW is a marvelous mood booster --- not to mention just downright delish
April 18, 2014

Rabbi Yonason Goldson: Clarifying one of the greatest philosophical conundrums in theology

Caroline B. Glick: The disappearance of US will

Megan Wallgren: 10 things I've learned from my teenagers

Lizette Borreli: Green Tea Boosts Brain Power, May Help Treat Dementia

John Ericson: Trying hard to be 'positive' but never succeeding? Blame Your Brain

The Kosher Gourmet by Julie Rothman Almondy, flourless torta del re (Italian king's cake), has royal roots, is simple to make, . . . but devour it because it's simply delicious

April 14, 2014

Rabbi Dr Naftali Brawer: Passover frees us from the tyranny of time

Greg Crosby: Passing Over Religion

Eric Schulzke: First degree: How America really recovered from a murder epidemic

Georgia Lee: When love is not enough: Teaching your kids about the realities of adult relationships

Cameron Huddleston: Freebies for Your Lawn and Garden

Gordon Pape: How you can tell if your financial adviser is setting you up for potential ruin

Dana Dovey: Up to 500,000 people die each year from hepatitis C-related liver disease. New Treatment Has Over 90% Success Rate

Justin Caba: Eating Watermelon Can Help Control High Blood Pressure

The Kosher Gourmet by Joshua E. London and Lou Marmon Don't dare pass over these Pesach picks for Manischewitz!

April 11, 2014

Rabbi Hillel Goldberg: Silence is much more than golden

Caroline B. Glick: Forgetting freedom at Passover

Susan Swann: How to value a child for who he is, not just what he does

Cameron Huddleston: 7 Financial Tasks You Should Tackle Right Now

Sandra Block and Lisa Gerstner: How to Profit From Your Passion

Susan Scutti: A Simple Blood Test Might Soon Diagnose Cancer

Chris Weller: Have A Slow Metabolism? Let Science Speed It Up For You

The Kosher Gourmet by Diane Rossen Worthington Whitefish Terrine: A French take on gefilte fish

April 9, 2014

Jonathan Tobin: Why Did Kerry Lie About Israeli Blame?

Samuel G. Freedman: A resolution 70 years later for a father's unsettling legacy of ashes from Dachau

Jessica Ivins: A resolution 70 years later for a father's unsettling legacy of ashes from Dachau

Kim Giles: Asking for help is not weakness

Kathy Kristof and Barbara Hoch Marcus: 7 Great Growth Israeli Stocks

Matthew Mientka: How Beans, Peas, And Chickpeas Cleanse Bad Cholesterol and Lowers Risk of Heart Disease

Sabrina Bachai: 5 At-Home Treatments For Headaches

The Kosher Gourmet by Daniel Neman Have yourself a matzo ball: The secrets bubby never told you and recipes she could have never imagined

April 8, 2014

Lori Nawyn: At Your Wit's End and Back: Finding Peace

Susan B. Garland and Rachel L. Sheedy: Strategies Married Couples Can Use to Boost Benefits

David Muhlbaum: Smart Tax Deductions Non-Itemizers Can Claim

Jill Weisenberger, M.S., R.D.N., C.D.E : Before You Lose Your Mental Edge

Dana Dovey: Coffee Drinkers Rejoice! Your Cup Of Joe Can Prevent Death From Liver Disease

Chris Weller: Electric 'Thinking Cap' Puts Your Brain Power Into High Gear

The Kosher Gourmet by Marlene Parrish A gift of hazelnuts keeps giving --- for a variety of nutty recipes: Entree, side, soup, dessert

April 4, 2014

Rabbi David Gutterman: The Word for Nothing Means Everything

Charles Krauthammer: Kerry's folly, Chapter 3

Amy Peterson: A life of love: How to build lasting relationships with your children

John Ericson: Older Women: Save Your Heart, Prevent Stroke Don't Drink Diet

John Ericson: Why 50 million Americans will still have spring allergies after taking meds

Cameron Huddleston: Best and Worst Buys of April 2014

Stacy Rapacon: Great Mutual Funds for Young Investors

Sarah Boesveld: Teacher keeps promise to mail thousands of former students letters written by their past selves

The Kosher Gourmet by Sharon Thompson Anyone can make a salad, you say. But can they make a great salad? (SECRETS, TESTED TECHNIQUES + 4 RECIPES, INCLUDING DRESSINGS)

April 2, 2014

Paul Greenberg: Death and joy in the spring

Dan Barry: Should South Carolina Jews be forced to maintain this chimney built by Germans serving the Nazis?

Mayra Bitsko: Save me! An alien took over my child's personality

Frank Clayton: Get happy: 20 scientifically proven happiness activities

Susan Scutti: It's Genetic! Obesity and the 'Carb Breakdown' Gene

Lecia Bushak: Why Hand Sanitizer May Actually Harm Your Health

Stacy Rapacon: Great Funds You Can Own for $500 or Less

Cameron Huddleston: 7 Ways to Save on Home Decor

The Kosher Gourmet by Steve Petusevsky Exploring ingredients as edible-stuffed containers (TWO RECIPES + TIPS & TECHINQUES)

Jewish World Review

74 DNA discoveries move cure closer for three cancers

By Eryn Brown

Massive gene-hunting effort involved cooperation of hundreds of scientists from around the world

JewishWorldReview.com |

LOS ANGELES — (MCT) A massive gene-hunting effort involving hundreds of scientists has identified 74 newly discovered regions of DNA that are associated with breast, ovarian and prostate cancers — diseases that strike about half a million Americans every year.

The international project, known as the Collaborative Oncological Gene-environment Study, or COGS, nearly doubled the number of genetic markers known to be linked with the three cancers. Their findings could lead to more effective ways to screen, study and treat these diseases.

"While these papers may not be what the average person is looking for — e.g., a cure for cancer — they have important near-term value" for medical researchers, said John Witte, an epidemiologist at the University of California, San Francisco, and co-author of a commentary on the work that appeared in Nature Genetics, one of five journals that published 13 studies detailing the COGS results. Witte was not a member of the collaboration.


Every weekday JewishWorldReview.com publishes what many in the media and Washington consider "must-reading". In addition to INSPIRING stories, HUNDREDS of columnists and cartoonists regularly appear. Sign up for the daily update. It's free. Just click here.

For the last decade or so, cancer researchers have been working hard to ferret out the DNA changes associated with cancers and other common afflictions. They examine the DNA of large groups of people with and without certain diseases to see if any genetic variations can be linked to particular conditions.

One hope has been to pinpoint the people at highest risk for developing health problems. Another has been to identify the individual genes that cause illness in the first place so that scientists can better understand how those genes cause harm and use that information to develop better treatments.

But the work has been difficult because many of the variations linked to diseases are turning out to be more rare than scientists had originally thought, said Harvard Medical School genetics professor Raju Kucherlapati, who was not involved in the COGS group.

By examining hundreds of thousands of locations on the genome in 250,000 people with and without cancer, the COGS study was able to reveal more associations than smaller studies could. In addition to confirming many genetic markers that had already been found, scientists discovered 41 new regions linked with overall risk for breast cancer, three associated with overall risk for ovarian cancer and 23 tied to overall risk for prostate cancer.

Researchers also found additional variations linked to subtypes of breast and ovarian cancer, and noted that 16 of the new regions associated with prostate cancer were linked to aggressive forms of the disease.

Generally, the risks associated with the genetic changes were modest — about 10 percent to 20 percent more than the small risks faced in the general population.

To put that in perspective, Kucherlapati said, more than half of women who have the most dangerous mutations in the BRCA1 and BRCA2 genes will develop breast cancer during their lives.

But relatively small increases in risk can add up to become significant, said geneticist Rosalind Eeles of the Institute for Cancer Research in Sutton, England, co-author of a study in Nature Genetics that detailed the prostate cancer findings.

In Eeles' paper, men who fell in the top 1 percent of risk were nearly five times more likely to develop prostate cancer than the rest of the men in the study. (According to the National Cancer Institute, 16 percent of American men will be diagnosed with prostate cancer in their lifetime.) Perhaps targeting such men for additional tests could improve screening, Eeles and her co-authors wrote.

Scientists said that looking for the small genetic changes — known as single nucleotide polymorphisms, or SNPs — in people who are already at high risk for disease could help physicians' early detection efforts.

"If you have a family history, the SNPs can improve the risk estimate," Eeles said, adding that much more research is needed before SNP screening would be ready for use.

In the meantime, both Witte and Kucherlapati said the COGS findings could help scientists study the genes that cause cancer, as well as other biological aspects of the disease.

The new data also underscore how much scientists still haven't figured out about how the genes we inherit contribute to our cancer risk.

For instance, it is thought that there are more than 1,000 genetic regions associated with breast cancer. Yet only 76 common variants have been identified so far, University of Cambridge cancer researcher Douglas Easton and co-authors wrote in one of the studies published in Nature Genetics.

In all, the scientists said, about a third of the variants believed to be associated with the three cancers had been discovered.

What explains the remaining two-thirds is "obviously" the $64 million question, Easton said.

Every weekday JewishWorldReview.com publishes inspiring reading material that will uplift you. Sign up today for the daily JWR update. It's free. Just click here.

Interested in a private Judaic studies instructor — for free? Let us know by clicking here.

Comment by clicking here.

© 2013, Los Angeles Times Distributed by MCT Information Services